These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 18357956)
1. The incretin system in the management of type 2 diabetes mellitus. Stephens JW Clin Med (Lond); 2010 Oct; 10(5):491-5. PubMed ID: 21117386 [No Abstract] [Full Text] [Related]
2. A New Treatment Strategy for Parkinson's Disease through the Gut-Brain Axis: The Glucagon-Like Peptide-1 Receptor Pathway. Kim DS; Choi HI; Wang Y; Luo Y; Hoffer BJ; Greig NH Cell Transplant; 2017 Sep; 26(9):1560-1571. PubMed ID: 29113464 [TBL] [Abstract][Full Text] [Related]
3. Glucagon Peptide Family and Adipose Tissue: Not that Intimate, just Acquaintances. Perez-Tilve D Endocrinology; 2020 Feb; 161(2):. PubMed ID: 31950149 [No Abstract] [Full Text] [Related]
5. [Glucagon-like peptide-1 (GLP-1), new target for the treatment of type 2 diabetes]. Scheen AJ Rev Med Liege; 2007 Apr; 62(4):217-21. PubMed ID: 17566392 [TBL] [Abstract][Full Text] [Related]
6. New therapies for diabetes. Green DE Clin Cornerstone; 2007; 8(2):58-63; discussion 64-5. PubMed ID: 18357956 [TBL] [Abstract][Full Text] [Related]
7. Incretin mimetics and DPP-4 inhibitors: new approach to treatment of type 2 diabetes mellitus. Siddiqui NI Mymensingh Med J; 2009 Jan; 18(1):113-24. PubMed ID: 19182763 [TBL] [Abstract][Full Text] [Related]
8. [GLP-1-based treatment of type 2 diabetes mellitus]. Knop FK; Vilsbøll T Ugeskr Laeger; 2007 May; 169(22):2095-9. PubMed ID: 17553390 [TBL] [Abstract][Full Text] [Related]
9. Exenatide and pramlintide: new glucose-lowering agents for treating diabetes mellitus. Hoogwerf BJ Cleve Clin J Med; 2006 May; 73(5):477-84. PubMed ID: 16708716 [TBL] [Abstract][Full Text] [Related]